Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Want to earn without upfront costs? Discover ways to earn today without any investment and start boosting your income now.
27,120 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Oil-driven weakness pushed the S&P 500 lower in a volatile March session. SPY skidded as energy names led declines, w...
New Glassnode data reveal a large share of Bitcoin sits in wallets with exposed public keys, highlighting where bitco...
SpaceX stock SPCX rebounds after a three-day selloff, with traders awaiting new catalysts as analysts weigh long-term...
Axon Enterprise stock popped as investors weighed the company’s expanding product lineup, software growth, and a grow...
A key change from the Social Security Administration will leave beneficiaries with one fewer way to receive payments....
Disney reports stronger-than-expected Q2 2026 results, lifting the stock 8% in early trading as streaming and parks r...
Stocks rally as AI names lead gains, but one gauge shows extraordinary greed. Investors weigh Buffett's caution again...
As the CLARITY Act markup arrives today, XRP struggles with a multi-week ceiling near $1.50. Traders say the vote cou...
Bitcoin options totaling 85,500 contracts with a $6.3 billion notional expire today, a larger-than-average end-of-mon...
Billionaire investor Bill Ackman warns that today's mega-cap trio—Microsoft, Meta, and Amazon—could echo Buffett's Be...
A rising concentration in a handful of tech names is signaling a wall street flashing warning for many investors. Thi...